These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 2800333

  • 1. DNase I hypersensitive site maps to the HBV enhancer.
    Akmal M, el-Ghor A, Burk RD.
    Virology; 1989 Oct; 172(2):478-88. PubMed ID: 2800333
    [Abstract] [Full Text] [Related]

  • 2. Transcription of the S gene in transgenic mice is associated with hypomethylation at specific sites and with DNase I sensitivity.
    Pourcel C, Tiollais P, Farza H.
    J Virol; 1990 Feb; 64(2):931-5. PubMed ID: 2296089
    [Abstract] [Full Text] [Related]

  • 3. Aberrant tissue specific expression of the transgene in transgenic mice that carry the hepatitis B virus genome defective in the X gene.
    Nagashima H, Imai M, Iwakura Y.
    Arch Virol; 1993 Feb; 132(3-4):381-97. PubMed ID: 8379855
    [Abstract] [Full Text] [Related]

  • 4. Significance of DNase I-hypersensitive sites in the long terminal repeats of a Moloney murine leukemia virus vector.
    Rasmussen JA, Gilboa E.
    J Virol; 1987 May; 61(5):1368-74. PubMed ID: 3573142
    [Abstract] [Full Text] [Related]

  • 5. Cell lineage specificity of chromatin configuration around the immunoglobulin heavy chain enhancer.
    Ford AM, Watt SM, Furley AJ, Molgaard HV, Greaves MF.
    EMBO J; 1988 Aug; 7(8):2393-9. PubMed ID: 2847917
    [Abstract] [Full Text] [Related]

  • 6. The mouse albumin promoter and a distal upstream site are simultaneously DNase I hypersensitive in liver chromatin and bind similar liver-abundant factors in vitro.
    Liu JK, Bergman Y, Zaret KS.
    Genes Dev; 1988 May; 2(5):528-41. PubMed ID: 3384331
    [Abstract] [Full Text] [Related]

  • 7. Tissue preferential expression of the hepatitis B virus (HBV) surface antigen gene in two lines of HBV transgenic mice.
    Burk RD, DeLoia JA, elAwady MK, Gearhart JD.
    J Virol; 1988 Feb; 62(2):649-54. PubMed ID: 2826823
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Specific sets of DNase I-hypersensitive sites are associated with the potential and overt expression of the rat albumin and alpha-fetoprotein genes.
    Nahon JL, Venetianer A, Sala-Trepat JM.
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2135-9. PubMed ID: 2436225
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An enhancer/locus control region is not sufficient to open chromatin.
    Reitman M, Lee E, Westphal H, Felsenfeld G.
    Mol Cell Biol; 1993 Jul; 13(7):3990-8. PubMed ID: 8321206
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Repression of liver-specific hepatitis B virus enhancer 2 activity by adenovirus E1A proteins.
    Chen ST, Su H, Yee JK.
    J Virol; 1992 Dec; 66(12):7452-60. PubMed ID: 1331530
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.